Arkolith/Insider Trading/WHWK/Form 4

Lennon David James

CHIEF EXECUTIVE OFFICER, DirectorWhitehawk Therapeutics, Inc. (WHWK) · full profile →Form 4 · filed Apr 3, 2026
Net Selling
Open-Market Buys
$0
Open-Market Sells
$93K
Net Open-Market Flow
-$93K
Transactions
4
2 non-derivative · 2 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Apr 2, 2026Sell(S)27K$3.48$93K794K
Apr 1, 2026Option exercise(M)776K——820K

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Apr 1, 2026Option exercise(M)776K—$00
Apr 1, 2026Grant(A)831K—$0831K

Transaction Codes

S
Open-market sale
M
Option exercise / conversion
A
Grant / award

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001995275-26-000006) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML